Current Report Filing (8-k)
July 21 2017 - 05:02PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 18, 2017
ADVAXIS,
INC.
(Exact
name of Registrant as Specified in its Charter)
Delaware
|
|
000-28489
|
|
02-0563870
|
(State
or Other Jurisdiction
of
Incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
305
College Road East
Princeton,
New Jersey, 08540
|
(Address
of Principal Executive Offices)
|
(609)
452-9813
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.[ ]
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers
On
July 18, 2017, Advaxis, Inc. (the “Company”) entered into an Employment Agreement (the “Employment Agreement”)
with Anthony Lombardo in connection with Mr. Lombardo’s assumption of the role of Interim Chief Executive Officer of the
Company, effective July 6, 2017, as previously disclosed in the Company’s Current Report on Form 8-K filed on July 6, 2017.
Under
the terms of the Employment Agreement, Mr. Lombardo’s base salary will be equal to $355,000 per year. Mr. Lombardo is also
eligible to receive a one-time lump-sum bonus equal to $88,000 payable within thirty (30) days after the effective date of the
Employment Agreement. Additionally, an annual discretionary bonus, targeted to 50% of Mr. Lombardo’s base salary, may be
granted if certain performance goals are met in the discretion of the Company’s Compensation Committee.
Further,
Mr. Lombardo will be entitled to cash severance payments if the Company terminates his employment without Just Cause (as defined
in the Employment Agreement) or if Mr. Lombardo resigns his employment for Good Reason (as defined in the Employment Agreement).
In
connection with the execution of the Employment Agreement, Mr. Lombardo also agreed to maintain Company Confidential Information
(as defined in the Employment Agreement).
The
foregoing summary of the Employment Agreement is qualified in its entirety by a copy of such agreement filed as Exhibit 10.1 hereto
and incorporated by reference.
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits.
The
following exhibit is filed as part of this report:
Exhibit
Number
|
|
Description
|
|
|
|
10.1
|
|
Employment
Agreement by and between Advaxis, Inc. and Anthony Lombardo, dated July 18, 2017.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
ADVAXIS,
INC.
|
Date:
July 21, 2017
|
|
|
|
By:
|
/s/
Sara Bonstein
|
|
|
Sara
Bonstein
|
|
|
Executive
Vice President and
Chief
Financial Officer
|
INDEX
TO EXHIBITS
Exhibit
Number
|
|
Description
|
|
|
|
10.1
|
|
Employment
Agreement by and between Advaxis, Inc. and Anthony Lombardo, dated July 18, 2017.
|
Ayala Pharmaceuticals (QX) (USOTC:ADXS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Ayala Pharmaceuticals (QX) (USOTC:ADXS)
Historical Stock Chart
From Mar 2023 to Mar 2024